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~ Moduletlen of  Smooth Muscle Cell 
MigretloNInvasion by Plasmln_ogen.Ac:,f~ltors, . 
Urok inue  Receptor, end Low gensny Ltpoprotem 
Receptor Related Protein 
Shunichire S. Okeda, Stephen R. Grobmyer, Elliot S. Barnethan. Univers[ly 
of pennsytvania, Philadelphia, PA 
Smooth muscle cell (SMC) migration is an early response to vascular in. 
jury contdb~n~ to the development of intimal thickening. Upregulation of 
several component£ of the plasminegan activator (PA) system have been 
documented after vascular injunJ. We utilized a Transwell tilter assay system 
and cultured human umbilical vein SMC to more thoroughly define the role of 
four different components of the PA system on SMC migmbsn: 1) plasmino- 
gen activafors, 2) plasmin, 3) PA receptors (e,g, u-PAR) and 4) PA clearance 
receptors (e.g. low density lipoprotein receptor elated protein, LRP). Active 
two chain urokinase stimulated random migration (1.9:1:3 fold increase, 
0.36 nM, p = 0.0001) which was inhibitsble by diisopropytiluorephosphate 
(DFP). plasmlnogen activator Inhibitor-1 (PAl-l) or apretinin. The aminater- 
minel fragment of u-PA (ATF) increased migration as well (1.4 :E 0.1 fold, p < 
0.001) but was net ichgoitable by apretinin. Low molecular weight u-PA also 
enhanced migration (1.5 • 0,3 told, p = 0.003); the effe~ was inhibltable by 
apretinin and was additive when combined with ATF. The stimulatory effect 
was not specific for u-PA in that t-PA also stimulated migration (1.7 :t: 0.1 
fold, 10 nM, p = 0.0001 ); the augmentation was inhibitsble by DFP, PAl-l, or 
apmtinin and was additive to the u-PA effect (2.4 • 0A fold, p < 0.02 vs. t-PA 
alone). Antibodies to either u.PAR or LRP inhibited migration (19 ± 9% and 
43 ± 4% of control, respectively, p = 0.0001) but only anti-u-PAR antibodies 
inhibited baseline SMC invasion (41 :l: 9% of control, p = 0.01 ) in a collagen 
gel assay. These data demonstrate the ability of several components of the 
PA system to modulate SMC migration and invasion in vifre via pfasmin 
dependent and independent mechanisms. 
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~75~--~ Efficient Perivascular Gene Adenovirus-Mediated 
Transfer and Protein DelP,-ery by e Transvaecular 
Injection Catheter 
Khawar Mehdi, Robert L Wilensky, Sang Hong Baek, Bruce C. Trapnsll, 
Keith L March. Krannert Institute of Cardiol~, Indiana University Medical 
Center, Indianapolis, IN; RL Roudebush VAMC, Indianapolis, IN; Genetic 
Therapy, Ir, corporated, Gaithersburg, MD 
Intralumlnsl delivery catheters have successfully delivered agents to vascu- 
lar tissue in vivo, but are characterized by limited efficiency, partially due to 
intxavascelar loss of agent. The kinetics of adanoviral sell attachment also 
dictate the need for prolonged vector exposure times to optimize transduc- 
tion. The use of needle-tipped il~.; ,%'tion catheters (NIC) capable of direct 
perivascular injection of agents may enhance delivery efficiency as well as 
transduction by intet3titial deposition of agent without he need for prolonged 
vascular occlusion. The delivery dis~'bution, efficiency and transduction prop- 
erties of NIC were evaluated in vivo in 18 normal porcine coronary artedee 
acutely following injection of 12Sl-elbumin or fiuorescein-conjugated hupadn; 
and 7 days after injection of a replication-deficient recombinant edenovirai 
vector encoding nuclear-targeted p-gelastosklase (~-gal) as a marker gene. 
The fractional delivery of albumin was 0.54 4- 0.3(P,o into the artedel wall, 
0.98 -t- 0.70% into the perivascular space, and 2.7 ~ 2.4% into podvascu- 
lar myocardium; while evaluation of the entire myocardium surrounding the 
target vessel confirmed presence of 15% of the total agent delivered. Ruo- 
reeceinaled hepedn was predominantly seen in the adventifia nd perivss- 
cular tissue, and was disth'buted longitudinally for distances of 15-20 ram. 
Adanovirai gone transfer was seen with high frequency in advantitia and 
perivascular tissues extending up to 10 mm from the target vessel, as well as 
in the epicardium overlying the delivery sites, suggesting convective vector 
transport; but medial transduction was limited. Cathetsr-based transvascalar 
injection provides for cumparatively elficlent agent delivery, and may repre- 
sent an approach to the genatio modulation of a range of perivescular tissues 
without he need for prolonged vascular occlusion. 
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~ Hepadn Reverses the Antipla;el¢~ Effect o f  N~ie  
Oxide 
Gilbert R. Upehurch, Jr., Jane E. Freedman, Yingyi Zhang, George 
N. Welch, Joseph Loscalzo. Brigham and Women's Hospital, Boston,/VIA; 
Boston Universfty School of Medicine, Boston, MA 
Hepadn has been shown to increase thromboxane .% generation by platelats 
in vivo, and we have shown that expression of the plalaiet activation antigen 
P-solectin is induced by hepadn. The mechanism for these adverse, pro- 
thrombotic effects of hopadn remains unknown. Since endothelium-dedved 
nit'do oxide (NO) is a potent inhibitor of platalat activation, we examined 
the effects of hepadn on the antlplatelat effects of this endothelial product. 
Increasing concentrations of hepadn (0, 0.5. 5. or 50 Ulmt) were incubated 
with gel-filtered platelets to which the NO-donor S-nitroso-glutathione was 
added and platelet aggregation responses to adenosine 5'-diphosphate de- 
termined. While Incubation of plateleto with hapadn alone did not alter the 
aggrsgafio, response and incubation with 1 p,M S-nitroso-glutathtone inhib- 
ited the normalized extent of aggregation by 50%, the addition of hepafln 
to S-nifreso-gfutalhione l d to a dose-dependent increase in aggregation 
response (ECso = 1 39 U/ml, p ,= 0.03 by ANOVA). Using the Gdess reaction 
and the abaorbance of the chmmophore of acidified nitrite, we observed a 
concomitant dose-dependent decrease in NO with increasing hepadn con- 
contmtions (IOso = 7.30 U/ml, p = 0.007 by ANOVA). The Increase In ag- 
gregation response correlated negatively with the decrease in nitrite in these 
experiments (R - -0.74). These data show that hepadn can impair the an- 
tiplataiet effects of nitric oxide and suggest that one mechanism by which 
hepadn promotes platelat activation in vivo is by attenuating the inhibitory 
effects of endothelium-dedved nitric OXide. 
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~ ' ~  Duel Inhibition of  Neutral Endopeptidaee (NEP) end 
Angiotensin Converting Enzyme (ACE) Suppresses 
Atherogeneeis and Improves Endothelial Function 
In Hypercholeeteretemlc Rabbits 
Iffikhar J. Kutlo, Vtrgiola M. Miller, George M. Lawson, John C. Bumott Jr.. 
Mayo Clini~ Rochester, MN 
NEP and ACE am coiocalized ectoenzymes which metabolize several va- 
soactive peptides. Combined inhibition of the two enzymes could have unique 
antiatharogentc effects by augmenting the anfimitogenic-vasorelaxing prop- 
erties of the natriuretio peptidas and kinlns whilst decreasing levels of angio- 
tensin II. We investigated the effects of UK-81262 (UK) (Pfizer), a dual 
inh~itor of NEP and ACE, on vascular reactivity and atherogenests In male 
New Zealand White rabbits fed a 1% cholesterol diet for 10 weeks. Animals 
wsm either untreated (n = 6), or treated with UK 5 mg/kg/day orally (n = 8). 
At 10 weeks, mean arterial blood pressure (86 ± 4 vs 81 4- 3 mmHg) and 
plasma cholestarel evels (1937 -4-195 vs 2022 ~: 162 mg/di) were compara- 
ble in the two groups. The percent surface area of the proximal thoracic aorta 
affected by athemma (measured after Oil-Red O staining) was significantly 
lower in the treated group (22 ~ 7=/0 vs 48 + 9%; p < 0.01). Endothelial 
dependent relaxations to acetylcheline, in vascular dngs from the thoracic 
aorta, were signifcantly greater in the UK treated group compared to the 
untreated group: 
MR ECS0 
Untreated 56 ~: 6. 6.4 ~ 0.34 
Treated 864. p_6*,(p < 0.001 ) 7.0 ± 0.03"(p < 0.02) 
MR = maximum relaxation. EC50 - concentretion causing a 50% decrease of 
phanylphflne induced contraction and expressed as a negative logarithm of the mo, 
lar concenlratton. 
These results demonstrate that chronic dual inhibition of ACE and NEP 
suppresses atherogenesis and improves endothelial function in hypercholes- 
terolemio states in the absence of any significant effects on blood pressure 
or plasma cholesterol. 
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~ ' - ]  Secondary Prevention in CAD: A Slgnmcant 
Correlation Between LOL-Cholesterol (LDL-C) 
Achieved Therapeutically and Extent of  Progression 
Reouctlon Clmms TOr LOL-C Target Levels < 100 
mg/dl 
H.P. Bestehom, U.F.E. Rensing, H. Roskamm, L. Benesch, G. BlOmchen, 
P. Mathes, L Kuppenbarger. HerzoZentrum Bad Krozingen; Fachklinik 
Rhein Ruhr Essen; lOin. Roderbirken Leichlingen; Klinik H6heorisd; CHUV 
Lausanne 
The Coronary Intervention Study (CIS) is a multicenter, andomized, double- 
blind, placel0o-controlled study to investigate the effect of lipid-lowering with 
simvastatin (S) on progression of coronary artery disease (CAD) in 254 men 
with documented CAD and hypercholesterelemia. Treatment with up to 40 
